Multiple Sclerosis Relapse Rates and Healthcare Costs with Generic Glatiramer Acetate: A Retrospective Claims Analysis of US Health Plan Data

被引：0
|
作者：
Kantor, Daniel [1 ]
Grabner, Michael [2 ]
Zhang, Xian [2 ]
Balu, Sanjeev [3 ]
Hall, Steven [3 ]
机构：
[1] Florida Atlantic Univ, Boca Raton, FL 33431 USA
[2] HealthCore Inc, Wilmington, DE USA
[3] Sandoz Inc, Princeton, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P129
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [21] A US RETROSPECTIVE COMMERCIAL CLAIMS ANALYSIS OF HEALTHCARE UTILISATION AND COSTS OF HUNTINGTON'S DISEASE BY STAGE
    Exuzides, A.
    To, T. M.
    Abbass, I
    Surinach, A.
    Fuller, R.
    Luo, J.
    VALUE IN HEALTH, 2020, 23 : S263 - S264
  • [22] Real-World Durability of Long-Term Relapse Rates Among Patients Multiple Sclerosis Receiving Fingolimod Therapy: A Retrospective US Claims Database Analysis
    Fox, Edward
    Johnson, Kristen
    Lin, Feng
    Signorovitch, James
    Li, Nanxin
    Peeples, Miranda
    Ristovska, Ljubica
    Souroutzidis, Ariadne
    Hong, Walter
    Herrera, Vivian
    NEUROLOGY, 2016, 86
  • [23] Healthcare resource utilization and costs in patients with eosinophilic granulomatosis with polyangiitis versus severe uncontrolled asthma: a retrospective analysis of US health insurance claims data
    Dolin, Paul
    Kielar, Danuta
    Shavit, Anat
    Keogh, Karina
    Rowell, Jennifer
    Edmonds, Chris
    Meyers, Juliana
    Esterberg, Elizabeth
    Nham, Tram
    Chen, Stephanie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB206 - AB206
  • [24] Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001–2010
    MerriKay Oleen-Burkey
    Anissa Cyhaniuk
    Eric Swallow
    BMC Neurology, 14
  • [25] Epidemiology and costs of multiple sclerosis in Switzerland: an analysis of health-care claims data, 2011-2015
    Blozik, Eva
    Rapold, Roland
    Eichler, Klaus
    Reich, Oliver
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 2737 - 2745
  • [26] Identifying disability level in multiple sclerosis patients in a US-based health plan claims database
    Berkovich, R.
    Fox, E.
    Okai, A.
    Ding, Y.
    Gorritz, M.
    Bartolome, L.
    Wade, R. L.
    Su, W.
    Russo, P.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 113 - 114
  • [27] Identifying disability level in multiple sclerosis patients in a US-based health plan claims database
    Berkovich, Regina
    Fox, Edward
    Okai, Annette
    Ding, Yao
    Gorritz, Magdaliz
    Bartolome, Lauren
    Wade, Rolin L.
    Su, Wendy
    Johnson, Kristen M.
    Russo, Patricia
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 46 - 53
  • [28] COMPLICATIONS AND HEALTH CARE COSTS OF INFLUENZA IN GERMANY: A RETROSPECTIVE CLAIMS DATA ANALYSIS
    Scholz, S.
    Damm, O.
    Ultsch, B.
    Schneider, U.
    Remschmidt, C.
    Weidemann, F.
    Wichmann, O.
    Greiner, W.
    VALUE IN HEALTH, 2016, 19 (07) : A411 - A411
  • [29] Retrospective US database analysis of persistence with glatiramer acetate vs. available disease-modifying therapies for multiple sclerosis: 2001-2010
    Oleen-Burkey, MerriKay
    Cyhaniuk, Anissa
    Swallow, Eric
    BMC NEUROLOGY, 2014, 14
  • [30] Incremental Healthcare Costs of Eosinophilic Granulomatosis with Polyangiitis (EGPA) Compared to Asthma: Retrospective Analysis of Commercial Claims Data in the United States (US)
    Bell, Christopher
    Meyers, Juliana
    Ajmera, Mayank
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 872 - 874
12345